» Articles » PMID: 18680596

Heavily Glycosylated, Highly Fit SIVMne Variants Continue to Diversify and Undergo Selection After Transmission to a New Host and They Elicit Early Antibody Dependent Cellular Responses but Delayed Neutralizing Antibody Responses

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2008 Aug 6
PMID 18680596
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lentiviruses such as human and simian immunodeficiency viruses (HIV and SIV) undergo continual evolution in the host. Previous studies showed that the late-stage variants of SIV that evolve in one host replicate to significantly higher levels when transmitted to a new host. However, it is unknown whether HIVs or SIVs that have higher replication fitness are more genetically stable upon transmission to a new host. To begin to address this, we analyzed the envelope sequence variation of viruses that evolved in animals infected with variants of SIVMne that had been cloned from an index animal at different stages of infection.

Results: We found that there was more evolution of envelope sequences from animals infected with the late-stage, highly replicating variants than in animals infected with the early-stage, lower replicating variant, despite the fact that the late virus had already diversified considerably from the early virus in the first host, prior to transmission. Many of the changes led to the addition or shift in potential-glycosylation sites-, and surprisingly, these changes emerged in some cases prior to the detection of neutralizing antibody responses, suggesting that other selection mechanisms may be important in driving virus evolution. Interestingly, these changes occurred after the development of antibody whose anti-viral function is dependent on Fc-Fcgamma receptor interactions.

Conclusion: SIV variants that had achieved high replication fitness and escape from neutralizing antibodies in one host continued to evolve upon transmission to a new host. Selection for viral variants with glycosylation and other envelope changes may have been driven by both neutralizing and Fcgamma receptor-mediated antibody activities.

Citing Articles

High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.

Ita S, Hill A, Lam E, Dufort F, Yang X, Newman R J Virol. 2018; 92(7).

PMID: 29343575 PMC: 5972902. DOI: 10.1128/JVI.01574-17.


Feline immunodeficiency virus (FIV) neutralization: a review.

Hosie M, Pajek D, Samman A, Willett B Viruses. 2011; 3(10):1870-90.

PMID: 22069520 PMC: 3205386. DOI: 10.3390/v3101870.


Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys.

Yeh W, Rahman I, Hraber P, Coffey R, Nevidomskyte D, Giri A J Virol. 2010; 84(12):6018-32.

PMID: 20357097 PMC: 2876635. DOI: 10.1128/JVI.02741-09.


Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers.

Mahalanabis M, Jayaraman P, Miura T, Pereyra F, Chester E, Richardson B J Virol. 2008; 83(2):662-72.

PMID: 18987151 PMC: 2612349. DOI: 10.1128/JVI.01328-08.

References
1.
Herbeck J, Nickle D, Learn G, Gottlieb G, Curlin M, Heath L . Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J Virol. 2006; 80(4):1637-44. PMC: 1367147. DOI: 10.1128/JVI.80.4.1637-1644.2006. View

2.
Cheng-Mayer C, Brown A, Harouse J, Luciw P, Mayer A . Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol. 1999; 73(7):5294-300. PMC: 112584. DOI: 10.1128/JVI.73.7.5294-5300.1999. View

3.
Li B, Gladden A, Altfeld M, Kaldor J, Cooper D, Kelleher A . Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol. 2006; 81(1):193-201. PMC: 1797245. DOI: 10.1128/JVI.01231-06. View

4.
Johnson P, Hamm T, Goldstein S, Kitov S, Hirsch V . The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology. 1991; 185(1):217-28. DOI: 10.1016/0042-6822(91)90769-8. View

5.
Chackerian B, Rudensey L, Overbaugh J . Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol. 1997; 71(10):7719-27. PMC: 192123. DOI: 10.1128/JVI.71.10.7719-7727.1997. View